Your browser doesn't support javascript.
loading
Obesity and triple-negative-breast-cancer: Is apelin a new key target?
Gourgue, Florian; Mignion, Lionel; Van Hul, Matthias; Dehaen, Natacha; Bastien, Estelle; Payen, Valery; Leroy, Baptiste; Joudiou, Nicolas; Vertommen, Didier; Bouzin, Caroline; Delzenne, Nathalie; Gallez, Bernard; Feron, Olivier; Jordan, Bénédicte F; Cani, Patrice D.
Afiliación
  • Gourgue F; Metabolism & Nutrition Research Group, Louvain Drug Research Institute, WELBIO (Walloon Excellence in Life sciences and BIOtechnology), UCLouvain, Université catholique de Louvain, Brussels, Belgium.
  • Mignion L; Biomedical Magnetic Resonance Research Group, UCLouvain, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
  • Van Hul M; Biomedical Magnetic Resonance Research Group, UCLouvain, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
  • Dehaen N; Metabolism & Nutrition Research Group, Louvain Drug Research Institute, WELBIO (Walloon Excellence in Life sciences and BIOtechnology), UCLouvain, Université catholique de Louvain, Brussels, Belgium.
  • Bastien E; Biomedical Magnetic Resonance Research Group, UCLouvain, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
  • Payen V; Pole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique, UCLouvain, Université catholique de Louvain, Brussels, Belgium.
  • Leroy B; Pole of Pediatrics, Institut de Recherche Expérimentale et Clinique, UCLouvain, Université catholique de Louvain, Brussels, Belgium.
  • Joudiou N; Laboratory of Proteomics and Microbiology, MS-Quanta Platform, Research Institute for Biosciences, University of Mons, Mons, Belgium.
  • Vertommen D; Nuclear and Electron Spin Technologies (NEST) Platform, Louvain Drug Research Institute (LDRI), UCLouvain, Université catholique de Louvain, Brussels, Belgium.
  • Bouzin C; de Duve Institute (DDUV), Université catholique de Louvain (UCLouvain), Brussels, Belgium.
  • Delzenne N; Imaging platform 2IP, Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Université catholique de Louvain, Brussels, Belgium.
  • Gallez B; Metabolism & Nutrition Research Group, Louvain Drug Research Institute, WELBIO (Walloon Excellence in Life sciences and BIOtechnology), UCLouvain, Université catholique de Louvain, Brussels, Belgium.
  • Feron O; Biomedical Magnetic Resonance Research Group, UCLouvain, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
  • Jordan BF; Pole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique, UCLouvain, Université catholique de Louvain, Brussels, Belgium.
  • Cani PD; Biomedical Magnetic Resonance Research Group, UCLouvain, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
J Cell Mol Med ; 24(17): 10233-10244, 2020 09.
Article en En | MEDLINE | ID: mdl-32681609
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas / Apelina / Obesidad Idioma: En Revista: J Cell Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas / Apelina / Obesidad Idioma: En Revista: J Cell Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2020 Tipo del documento: Article